Drug Retention Rates of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients with Therapy-Induced Lymphopenia

Drug Retention Rates of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients with Therapy-Induced Lymphopenia

Objectives: To determine whether drug-induced lymphocytopenia is associated with drug retention rates of JAKi (tofacitinib or baricitinib) in rheumatoid arthritis (RA) patients. Methods: Patients with RA who were initiated with tofacitinib (<i>n</i> = 38) or baricitinib (<i>n</i...

Full description

Bibliographic Details
Main Authors: Jumpei Temmoku, Masayuki Miyata, Eiji Suzuki, Yuya Sumichika, Kenji Saito, Shuhei Yoshida, Haruki Matsumoto, Yuya Fujita, Naoki Matsuoka, Tomoyuki Asano, Shuzo Sato, Hiroshi Watanabe, Kiyoshi Migita
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Journal of Clinical Medicine
Subjects:
rheumatoid arthritis
Janus kinase inhibitor
lymphopenia
drug retention rate
Online Access:https://www.mdpi.com/2077-0383/12/14/4827

Internet

https://www.mdpi.com/2077-0383/12/14/4827

Similar Items